null

Vibostolimab (Anti-TIGIT) Biosimilar Antibody

SKU:
HDBS0027
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
TIGIT
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Vibostolimab (Anti-TIGIT) Biosimilar Antibody (HDBS0027)

The Anti-TIGIT (Vibostolimab) Biosimilar Monoclonal Antibody (HDBS0027) is a cutting-edge tool for researchers investigating the TIGIT protein, a key player in immune regulation and a potential target for cancer therapy. This antibody, produced using advanced biosimilar technology, shows high specificity for TIGIT in human samples and is validated for use in various applications, including immunohistochemistry and flow cytometry.TIGIT, also known as T cell immunoreceptor with Ig and ITIM domains, is a co-inhibitory receptor that plays a crucial role in regulating T cell activity and immune responses. Its interaction with ligands such as CD155 and CD112R on antigen-presenting cells helps to dampen immune responses and promote immune tolerance.

Targeting TIGIT has emerged as a promising strategy for enhancing anti-tumor immune responses and overcoming immune evasion in cancer.The Anti-TIGIT (Vibostolimab) Biosimilar Monoclonal Antibody (HDBS0027) offers researchers a reliable tool to study TIGIT expression and function in various cell types and disease models. Its use can contribute to the development of novel immunotherapies for cancer and other immune-related disorders by uncovering the underlying mechanisms of TIGIT-mediated immune regulation.